Skip to main content

Table 2 RNAseq comparing no treatment controls versus 18 h treatment with: a.) control versus MP1 at 500 nM, b.) control versus TEM alone at 1 μM, and c) control versus combination of MP1 plus TEM. All treatments were performed in triplicate and fold change calculated from the ratio of treatment over control

From: Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus

a.)

Gene

Change

p-value

Cntrl#1

Cntrl#2

Cntrl #3

MP1#1

MP1#2

MP1#3

MYCN

−2.0

6.09 E-179

2125

2166

2202

1092

1087

1096

 MCL-1

−1.18

3.38E-09

318

309

315

265

268

267

 LCII

+ 1.8

4.08 E-59

67.5

70.7

76.0

135

128.9

131.4

 LCI

+ 1.6

1.38 E-03

2.68

3.8

2.67

4.23

6.13

4.27

 PARP1

−1.5

8.56 E-52

699

711.6

689.6

451.8

466.3

463.9

 BRD-4

+ 1.07

0.15

77.3

75.5

75.2

84.5

82.2

77.4

 Bcl-2

1.76

1.09 E-35

33.7

34.6

34.1

64.0

50.5

56.9

 BAX

−1.39

8.51 E-12

46.1

47.6

43.4

35.0

31.5

32.0

b.)

Gene

Change

p-value

Cntrl#1

Cntrl #2

Cntrl #3

TEM#1

TEM#2

TEM#3

 MYCN

1.0

0.35

2125

2166

2202

2264

2140

2232

 MCL-1

−1.12

2.48E-05

318

309

315

281

282

276

 LCII

+ 1.3

1.44 E-10

67.5

70.7

76.0

92.7

92.5

89.7

 LCI

+ 1.5

0.004

2.68

3.8

2.67

5.1

4.4

4.4

 PARP1

−1.2

1.01E-08

699

712

690

580

617

599

 BRD-4

−1.06

0.20

77.3

75.5

75.2

70.4

71.4

72.7

 Bcl-2

1.45

9.03 E-16

33.7

34.6

34.1

49.2

52.0

47.7

 BAX

−1.14

0.007

46.1

47.6

43.4

42.7

37.3

40.6

c.)

Gene

Change

p-value

Cntrl#1

Cntrl #2

Cntrl #3

MP1 + TEM #1

MP1 + TEM #2

MP1 + TEM #3

 MYCN

−1.6

9.1E-89

2125

2166

2202

1338

1347

1356

 MCL-1

−1.2

1.29E-08

318

309

315

266

271

269

 LCII

+ 1.7

2.28 E-42

67.5

70.7

76.0

113

125

120

 LCI

+ 2.5

2.11E11

2.68

3.8

2.67

8.19

8.21

6.5

 PARP1

−1.6

6.48E-64

699

712

690

432

440

447

 BRD-4

−1.09

0.078

77.3

75.5

75.2

78.6

62.5

68.8

 Bcl-2

1.94

5.9 E-51

33.7

34.6

34.1

66.2

63.8

68.5

 BAX

−1.29

8.67 E-08

46.1

47.6

43.4

34.3

36.5

35.8